Diabetes Treatment in China for International Patients
China offers modern endocrinology and metabolic care for Type 1 and Type 2 diabetes, plus active research in islet-cell replacement, immune therapies, remission strategies and new diabetes technologies. The right pathway depends on the diagnosis, complications and what problem the patient is actually trying to solve.
Can China cure diabetes? There is no routine universal cure for Type 1 or Type 2 diabetes.
Type 1 still requires insulin-based treatment for most patients. Some people with Type 2 can achieve
remission. China’s widely shared “cure” stories are important research signals, but a published
case or clinical trial is not the same as a treatment package available to every international patient.
✓ Standard care separated from research
✓ Named hospitals and trial IDs
✓ No cure guarantee
✓ Travel only after case review
Choose the Right Diabetes Path in China
These pages answer different patient questions. Start with the one that matches your actual reason for considering China.
Type 1 diabetes
Type 1 Diabetes Treatment in China
Insulin, CGM and automated insulin delivery, difficult cases, islet replacement, trial eligibility and current research.
TYPE 1 PATH →
Type 2 diabetes
Type 2 Diabetes Treatment in China
Remission, weight and metabolic treatment, complications, metabolic surgery and experimental research.
TYPE 2 PATH →
Cell therapy
Stem Cell Therapy for Diabetes in China
Published evidence, islet-cell research, mesenchymal-cell studies, commercial packages and red flags.
STEM-CELL EVIDENCE →
Clinical research
Diabetes Clinical Trials in China
Current trial IDs, interventions, hospitals, recruitment-status freshness, basic eligibility and foreign-patient access.
TRIAL TRACKER →
Hospital selection
Best Diabetes Hospitals in China
Compare PUMCH, Ruijin, West China, Second Xiangya and Tianjin First Center by case fit and international access.
HOSPITAL SHORTLIST →
Cost
Diabetes Treatment Cost in China
Official public price examples, routine care vs experimental treatment, international-patient costs and hospital-specific quotes.
COST GUIDE →
Type 1 vs Type 2: Why the China Path Is Different
| Type 1 diabetes | Type 2 diabetes | |
|---|---|---|
| Core problem | Autoimmune destruction of insulin-producing beta cells causes severe insulin deficiency. | Insulin resistance plus progressive beta-cell dysfunction, often associated with excess weight and metabolic disease. |
| Standard treatment | Insulin replacement, CGM, education and often pump/AID technology. | Individualized medication, weight management, cardiovascular/kidney risk treatment and insulin when required. |
| Can remission occur? | Routine insulin-free remission is not established as standard care. | Yes, some patients can achieve remission, especially after substantial sustained weight loss or metabolic surgery. |
| China research angle | Stem-cell-derived islets, beta-cell replacement and experimental immune approaches. | Remission-focused regimens, new drugs, procedures and cell-therapy studies. |
| When travel may make sense | Difficult control, severe hypoglycemia, complications, tertiary second opinion or a specific trial inquiry. | Complex metabolic disease, serious complications, surgery evaluation, specialist second opinion or a specific study. |
What the China Diabetes “Cure” Headlines Actually Mean
The research is real; the universal cure claim is not. In 2024, a Chinese first-in-human report in
Cell described sustained insulin independence after transplantation of autologous chemically induced
pluripotent-stem-cell-derived islets in one patient with Type 1 diabetes. That is an important proof of concept,
not evidence that every patient can book the same result.
What happened in a defined study
A peer-reviewed paper can establish the protocol, patient population, follow-up and observed outcome. It does not make the treatment universally available.
A protocol that may be recruiting
Eligibility, study site and recruitment status can be checked in a registry. The investigator still decides whether the patient can enroll.
A treatment sold for cash
A self-pay “stem-cell diabetes package” is not automatically the same product, cell type, dose or protocol used in a published paper or registered trial.
For current China study IDs and recruitment-status checks, use our Diabetes Clinical Trials in China tracker.
Which Diabetes Hospitals in China Should International Patients Consider?
There is no universal #1 hospital. The best centre depends on whether the patient needs complex endocrinology, metabolic care, diabetic-foot treatment, diabetes classification or a specific experimental protocol.
PUMCH / West China Hospital
Large tertiary hospitals can be strong choices when diabetes is accompanied by kidney, cardiovascular, vascular, wound or other complicated disease.
Ruijin / Second Xiangya / exact trial site
Research-oriented patients may need a national metabolic centre or the exact hospital running the relevant protocol rather than the most famous hospital overall.
See the full comparison, including international-access labels: Best Diabetes Hospitals in China for International Patients.
How Much Does Diabetes Treatment in China Cost?
There is no single national diabetes-treatment package price. A routine endocrine consultation and
laboratory work-up are completely different from inpatient complication treatment, metabolic surgery or
experimental cell-therapy screening.
For an international patient, the useful number is a hospital-specific estimate after records review. Public Chinese medical price schedules can provide reference points for individual tests, but they should not be converted into a fake medical-tourism package.
See our full breakdown: Diabetes Treatment Cost in China.
When Does Travelling to China for Diabetes Treatment Make Sense?
A defined problem that needs a specific centre
- Difficult Type 1 or Type 2 control despite documented treatment
- Repeated severe hypoglycemia
- Major kidney, cardiovascular or diabetic-foot complications
- Complex obesity/metabolic disease or surgery evaluation
- A specialist second opinion at a named tertiary hospital
- A specific registered clinical trial you want screened
A generic “China cure” promise
- Routine medication refill or simple HbA1c follow-up
- A clinic that cannot name the exact protocol
- A treatment sold identically for Type 1 and Type 2
- A guaranteed insulin-free result before medical review
- Paying before anyone examines HbA1c, C-peptide or complications
- Booking flights before hospital or study-team confirmation
What Medical Records Should You Send First?
Core diabetes file
- Type 1, Type 2 or uncertain diagnosis
- Age and year diagnosed
- Latest HbA1c
- Current medication and insulin dose
- CGM report if available
- C-peptide and autoantibodies if relevant
Complications and your China goal
- Kidney function / urine albumin
- Cardiovascular history
- Eye / retinopathy reports
- Foot ulcer / vascular history
- Previous hospitalizations or surgery
- Trial ID, hospital name or stem-cell offer if you already found one
How the China Diabetes Case-Review Process Works
Send the medical file
We identify the diabetes type, current treatment, complications and the reason you are considering China.
Choose the right pathway
Routine specialist care, complications, metabolic treatment, hospital second opinion, or a research/trial inquiry.
Contact a relevant centre
Where appropriate, we ask whether the hospital or study team will review an overseas case and what additional information is required.
Plan after acceptance
Expected costs, stay length, invitation/visa and travel planning come after a realistic medical route has been confirmed.
Send Your Diabetes Records Before Choosing a Hospital or Treatment Package
Tell us whether the case is Type 1 or Type 2, what treatment you use now, your latest HbA1c and what you want from China. If you already found a hospital, clinical trial or stem-cell offer, send that too.
✓ No obligation to book
✓ No cure guarantee
✓ Hospital/trial route checked before travel
Frequently Asked Questions
Direct answers to the main questions international patients ask about diabetes treatment in China.
Did China cure diabetes?
No universal cure has been established. Chinese researchers have reported important experimental results, including a 2024 Type 1 diabetes case with sustained insulin independence after stem-cell-derived islet transplantation. That is proof of concept from a selected study, not a routine cure available to every patient.
What is the standard treatment for Type 1 diabetes in China?
Standard Type 1 diabetes care remains insulin-based and can include continuous glucose monitoring, insulin pumps or automated insulin-delivery systems, education and screening for complications. Experimental islet or immune-cell studies are a separate pathway.
Can Type 2 diabetes go into remission?
Yes, some people with Type 2 diabetes can achieve remission. International consensus uses remission rather than cure when HbA1c remains below 6.5% for at least three months without usual glucose-lowering medication. Remission is not guaranteed and diabetes can recur.
Are diabetes clinical trials in China open to foreigners?
Possibly, but a registry status of “Recruiting” does not prove international access. The study site must confirm medical eligibility, nationality or residency requirements, language, required time in China and whether overseas follow-up is possible.
What are the best diabetes hospitals in China?
There is no single best hospital for every case. PUMCH, Ruijin Hospital, West China Hospital, the National Clinical Research Center for Metabolic Diseases at Second Xiangya Hospital and Tianjin First Center Hospital can each be relevant for different clinical or research needs. The correct choice depends on the diabetes type, complications and treatment goal.
How much does diabetes treatment in China cost?
There is no single national package price. Cost depends on the hospital, tests, devices, complication care, admission, surgery or experimental pathway. International patients should request a written case-specific estimate from a named hospital after their records have been reviewed.
Is stem-cell therapy for diabetes available in China?
China has published diabetes cell-therapy research and registered clinical studies, but this does not mean there is a routine licensed stem-cell cure for Type 1 or Type 2 diabetes. Commercial packages should be checked against the exact cell product, hospital, protocol or trial ID before payment.
What records should I send for a diabetes treatment review in China?
Send your diabetes type, age, year diagnosed, latest HbA1c, current medication and insulin dose, CGM report if available, C-peptide and autoantibodies when relevant, major kidney, cardiovascular, eye or foot complications, and any hospital, trial ID or treatment offer you are considering.
Evidence and Primary Sources
- World Health Organization — Diabetes. WHO explains the distinction between major diabetes types and that people with Type 1 diabetes require insulin. WHO diabetes fact sheet.
- American Diabetes Association — Standards of Care in Diabetes—2026. Current standards for insulin, diabetes technology, individualized Type 2 treatment, weight management and metabolic surgery. ADA Standards of Care 2026.
- ADA-led international consensus — Type 2 diabetes remission. Remission is defined using HbA1c below 6.5% for at least three months without usual glucose-lowering pharmacotherapy. Consensus report.
- Wang S. et al., Cell (2024), PMID 39326417. Preliminary first-in-human report of chemically induced pluripotent-stem-cell-derived islet transplantation in one Type 1 diabetes patient. PubMed record.
- Parkmega China Diabetes Clinical Trial Tracker. Current trial IDs, sites, status freshness and foreign-patient-access caveats are maintained on a separate page so this hub does not hard-code quickly changing recruitment information. Diabetes Clinical Trials in China.
Evidence note: medical research, trial recruitment and international-patient access can change. A publication or registry record does not automatically mean a treatment is commercially available or suitable for a specific patient.
Medical note: This page is for medical-travel research and hospital matching. It is not medical advice and should not be used to stop insulin or change diabetes medication without the treating clinical team.
Start With the Medical File, Not With a “Cure” Advertisement
Send your records and the question you want answered. We’ll identify whether the next useful step is Type 1 or Type 2 specialist care, complication management, a hospital shortlist, a cost estimate or a specific clinical-trial inquiry.